Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis

Five days following the 3rd cycle of nivolumab, a monoclonal antibody, which acts as immune checkpoint inhibitor against the programmed cell death protein-1, for metastatic lung adenocarcinoma, a 56-year-old woman presented at the hospital critically ill. On admission, she had severe diabetic ketoac...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Endocrinol Diabetes Metab Case Rep
Main Authors: Tzoulis, Ploutarchos, Corbett, Richard W, Ponnampalam, Swarupini, Baker, Elly, Heaton, Daniel, Doulgeraki, Triada, Stebbing, Justin
Format: Artigo
Sprog:Inglês
Udgivet: Bioscientifica Ltd 2018
Fag:
Unusual Effects of Medical Treatment
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5863245/
https://ncbi.nlm.nih.gov/pubmed/29576870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-18-0111
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker